ATAGI Statement for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions More info
IVIg use for Heparin induced thrombocytopenia (HIT) and Vaccine induced thrombotic thrombocytopenia (VITT) More info
THANZ and HSANZ joint statement regarding the potential risk of thrombotic/bleeding events after COVID‐19 vaccination More info
Suspected Vaccine Induced Prothrombotic Immune Thrombocytopenia (VIPIT): THANZ Advisory Statement (check for weekly updates) More info
SAVE THE DATE- From Bench to Publication: How Pathology Scientists Conduct Research webinar More info
